Prostate Cell News Volume 15.06 | Feb 16 2024

    0
    75








    2024-02-16 | PCN 15.06


    Prostate Cell News by STEMCELL Technologies
    Vol. 15.06 – 16 February, 2024
    TOP STORY

    Stromal-Derived MAOB Promotes Prostate Cancer Growth and Progression

    Mechanistically, monoamine oxidase B (MAOB) induced a reactive stroma with activated marker expression, increased extracellular matrix remodeling, and acquisition of a protumorigenic phenotype through enhanced production of reactive oxygen species.
    [Science Advances]

    Full Article
    Reliably Generate Spheroids with AggreWell™
    PUBLICATIONSRanked by the impact factor of the journal

    Exploiting Epigenetic Targets to Overcome Taxane Resistance in Prostate Cancer

    Researchers identified BRPF reader proteins, along with several epigenetic groups that acted as targets effectively reversing the resistance mediated by ABCB1.
    [Cell Death & Disease]

    Full Article

    Germline Sequencing in Men with Metastatic Castration-Resistant Prostate Cancer from the BARCODE2 Study Reveals a Wide Range of Pathogenic Variants in DNA Repair Genes

    The authors explored the prevalence of germline genetic mutations in men with metastatic castration-resistant prostate cancer recruited to the BARCODE2 trial.
    [British Journal Of Cancer]

    Full Article

    Identification Macrophage Signatures in Prostate Cancer by Single-Cell Sequencing and Machine Learning

    Investigators downloaded prostate cancer single-cell sequencing data and second-generation sequencing data from multiple public databases. From these data, they identified characteristic genes associated with tumor-associated macrophages clusters.
    [Cancer Immunology Immunotherapy]

    Full Article

    Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts

    Investigators used LuCaP patient-derived xenograft tumors, clinically relevant models that reflects and retains key features of the tumor from advanced prostate cancer patients.
    [Molecular Cancer Research]

    Abstract

    Discovery of a Small-Molecule NDR1 Agonist for Prostate Cancer Therapy

    The authors characterized a small-molecule agonist named aNDR1, which specifically bound to Nuclear Dbf2-related kinase 1 (NDR1) and potently promoted NDR1 expression, enzymatic activity and phosphorylation.
    [Frontiers In Pharmacology]

    Full Article

    Cancer-Associated Fibroblast Exosomes Promote Prostate Cancer Metastasis through miR-500a-3p/FBXW7/HSF1 Axis Under Hypoxic Microenvironment

    Investigators discovered pronounced hypoxia in primary lesions of metastatic prostate cancer (mPCa). The exosomes secreted by cancer-associated fibroblasts under hypoxic conditions significantly enhance PCa metastasis both in vitro and in vivo.
    [Cancer Gene Therapy]

    Abstract

    Prognostic and Predictive Analyses of Circulating Plasma Biomarkers in Men with Metastatic Castration Resistant Prostate Cancer Treated with Docetaxel/Prednisone with or without Bevacizumab

    CALGB 90401 (Alliance) was a Phase III trial of 1050 patients with metastatic castration-resistant prostate cancer comparing docetaxel, prednisone, bevacizumab (DP+B) versus DP alone.
    [Prostate Cancer And Prostatic Diseases]

    Abstract

    Enhancing CAR T Cell Therapy through In Silico Modeling of Hinge Sequence Length Based on Epitope Location

    Investigators built an in silico model combining Alphafold2 and all-atom molecular dynamics to understand and predict an optimal hinge amino acid sequence length for a given single-chain variable fragment targeting a specific cancer antigen.
    [Biophysical Journal]

    Abstract
    Enjoy your weekend. Your cells will too. Reduce medium acidosis with mTeSR™ Plus.
    REVIEWS

    RNA N6-Methyladenosine Modifications in Urological Cancers: From Mechanism to Application

    Scientists summarize the current evidence indicating that aberrant or dysregulated N6‐methyladenosine modification is associated with urological cancer development, progression and prognosis.
    [Nature Reviews Urology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Fred Hutch Launches Rare Cancer Research Effort

    Dr. Taran Gujral and his lab created a drug-matching platform that uses artificial intelligence to help researchers, clinicians and, most importantly, patients find additional uses for drugs that have already gone through clinical trials and received approval from the US FDA.
    [Fred Hutch Cancer Center]

    Press Release

    New Research Shows Little Risk of Infection From Prostate Biopsies

    Infections after a prostate biopsy are rare, but they do occur. Now research shows that fewer than 2% of men develop confirmed infections after prostate biopsy, regardless of the technique used.
    [Harvard Health Publishing]

    Press Release
    FEATURED EVENT

    39th Annual EAU Congress

    April 5 – 8, 2024
    Paris, France

    > See All Events

    JOB OPPORTUNITIES

    Department Chair – Cell Biology and Human Anatomy

    UC Davis – Davis, California, United States

    Postdoctoral Scientists – Molecular Basis of Cancer

    Cyprus Cancer Research Institute – Aglandjia, Cyprus

    Research Assistant – Molecular Basis of Cancer

    Cyprus Cancer Research Institute – Aglandjia, Cyprus

    Senior Research Assistant – Epigenetics & Molecular Carcinogenesis

    University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    Research Fellow – Structural Biology of RNA

    University of Birmingham – Birmingham, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2